These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 3298130

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Results of random screening of possible antineoplastic agents in Japan using mouse cancer. 3].
    Gan To Kagaku Ryoho; 1984 Sep; 11(9 Pt 2):1899-2096. PubMed ID: 6497404
    [No Abstract] [Full Text] [Related]

  • 4. Development and cross-resistance characteristics of a subline of P388 leukemia resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide.
    Johnson RK, Howard WS.
    Eur J Cancer Clin Oncol; 1982 May; 18(5):479-87. PubMed ID: 6956514
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt on leukemic infiltration of brain and liver in mice bearing P388 leukemia.
    Sava G, Giraldi T, Bartoli-Klugmann F, Decorti G, Mallardi F.
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):287-9. PubMed ID: 6538492
    [No Abstract] [Full Text] [Related]

  • 7. Comparative antineoplastic activity against P388 leukemia of 9-beta-D-arabinofuranosyladenine (araA) and 9-beta-(2'-azido-2'-deoxy-D-arabinofuranosyl) adenine (arazide).
    Lee SH, Thomas LK, Unger FM, Christian R, Sartorelli AC.
    Int J Cancer; 1981 May 15; 27(5):703-8. PubMed ID: 6974703
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antitumour activity of some cyclophosphazenes.
    Labarre JF, Faucher JP, Levy G, Sournies F, Cros S, François G.
    Eur J Cancer (1965); 1979 May 15; 15(5):637-43. PubMed ID: 510331
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Absence of antitumor activity of ORG 5895, a 11 beta-aziridinylmethyl derivative of estradiol, on the MXT mammary tumor and the P388 leukemia.
    Devleeschouwer N, Leclercq G, Danguy A, Atassi G.
    Cancer Chemother Pharmacol; 1982 May 15; 8(3):315-6. PubMed ID: 7127663
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antitumor activity of MST-16, a novel derivative of bis(2,6-dioxopiperazine), in murine tumor models.
    Narita T, Yaguchi S, Komatsu T, Takase M, Hoshino A, Inaba M, Tsukagoshi S.
    Cancer Chemother Pharmacol; 1990 May 15; 26(3):193-7. PubMed ID: 2357766
    [Abstract] [Full Text] [Related]

  • 16. Effect of 3'-amino-3'-deoxythymidine on L1210 and P388 leukemias in mice.
    Lin TS, Fischer PH, Prusoff WH.
    Biochem Pharmacol; 1982 Jan 01; 31(1):125-8. PubMed ID: 7059345
    [No Abstract] [Full Text] [Related]

  • 17. [Mechanisms of the antitumor action of spirobromine in mice with leukemia P-388].
    Sokolova IS, Riabokon' NA, Chernov VA, Gorbacheva LB.
    Izv Akad Nauk SSSR Biol; 1989 Jan 01; (5):660-5. PubMed ID: 2584530
    [Abstract] [Full Text] [Related]

  • 18. Therapy of P388 leukemia with benzaldehyde.
    Balázová E, Koza I.
    Neoplasma; 1988 Jan 01; 35(6):725-8. PubMed ID: 3221939
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological evaluation of combination therapy of P388 leukemia with cyclophosphamide and pyrimidinones.
    Li LH, Wallace TL, Hamilton RD, DeKoning TF.
    Int J Immunopharmacol; 1987 Jan 01; 9(1):31-9. PubMed ID: 3583503
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.